<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00703014</url>
  </required_header>
  <id_info>
    <org_study_id>P05712</org_study_id>
    <secondary_id>2004-004772-36</secondary_id>
    <secondary_id>38821</secondary_id>
    <secondary_id>MK-8962-005</secondary_id>
    <nct_id>NCT00703014</nct_id>
  </id_info>
  <brief_title>Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)</brief_title>
  <official_title>Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Controlled Ovarian Stimulation in Clinical Trial 38819 for Org 36286 (Corifollitropin Alfa)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this trial was to evaluate whether Corifollitropin Alfa treatment for the
      induction of multifollicular growth in women undergoing controlled ovarian stimulation (COS)
      prior to in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) was safe for
      pregnant participants and their offspring. The primary endpoint was the take-home baby rate
      calculated as the number of participants with an ongoing pregnancy in Base Trial P05787
      (NCT00696800) with at least one live born infant relative to the number of participants in
      the Base Trial, and to the number of participants in the Base Trial with Embryo Transfer
      (ET).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a follow-up protocol to prospectively monitor pregnancy, delivery, and neonatal
      outcome of all women who were treated with Corifollitropin Alfa or recFSH and became pregnant
      during Base Trial P05787 (NCT00696800). For this trial, no study specific assessments are
      required, but information as obtained in standard practice will be used.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 13, 2006</start_date>
  <completion_date type="Actual">March 15, 2009</completion_date>
  <primary_completion_date type="Actual">April 18, 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Mothers in Current Follow Up Trial Experiencing Adverse Events (AEs)</measure>
    <time_frame>Up to one day following delivery (up to 1 year)</time_frame>
    <description>An AE is any untoward medical occurrence in a trial participant administered a pharmaceutical product, and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign (including laboratory finding), symptom, or disease temporally associated with the use of investigational medicinal product.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Mothers in Current Follow Up Trial Experiencing Serious AEs (SAEs)</measure>
    <time_frame>Up to one day following delivery (up to 1 year)</time_frame>
    <description>A SAE is any untoward medical occurrence that at any dose resulted in the following: death, was life threatening, required in-patient hospitalization or prolongation of existing hospitalization, persistent or significant disability/incapacity, or was a congenital anomaly/birth defect.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Infants Born in Current Follow Up Trial Experiencing AEs</measure>
    <time_frame>Up to 12 weeks following delivery (up to 1 year)</time_frame>
    <description>An AE is any untoward medical occurrence in a trial participant administered a pharmaceutical product, and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign (including laboratory finding), symptom, or disease temporally associated with the use of investigational medicinal product.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Infants in Current Follow Up Trial Experiencing SAEs</measure>
    <time_frame>Up to 12 weeks following delivery (up to 1 year)</time_frame>
    <description>A SAE is any untoward medical occurrence that at any dose resulted in the following: death, was life threatening, required in-patient hospitalization or prolongation of existing hospitalization, persistent or significant disability/incapacity, or was a congenital anomaly/birth defect.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Mothers From the Base Trial P05787 With at Least One Live Born Infant (Take-home Baby Rate) Relative to the Number of Participants in the Base Trial.</measure>
    <time_frame>At least 10 weeks after embryo transfer in Base Trial P05787 up to birth in current follow up Trial (up to 1 year)</time_frame>
    <description>The take-home baby rate is 100 X the number of participants with an ongoing pregnancy in Base Trial P05787 (NCT00696800), from the Intent-to-Treat (ITT) group, with at least one live born infant relative to the number of participants in the Base Trial.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Mothers From the Base Trial P05787 With at Least One Live Born Infant (Take-home Baby Rate) Relative to the Number of Participants From the Base Trial With Embryo Transfer.</measure>
    <time_frame>At least 10 weeks after embryo transfer in Base Trial P05787 up to birth in current Follow Up Trial (up to 1 year)</time_frame>
    <description>The take-home baby rate is 100 X the number of participants with an ongoing pregnancy in Base Trial P05787 (NCT00696800), from the ITT group, with at least one live born infant relative to the number of participants from the Base Trial with embryo transfer.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">541</enrollment>
  <condition>Pregnancy</condition>
  <condition>Neonates</condition>
  <arm_group>
    <arm_group_label>Mothers Corifollitropin Alfa 150 µg</arm_group_label>
    <description>Participants from the Base Trial P05787 who received a single subcutaneous (SC) injection of 150 µg Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections from Stimulation Days 1 to 7 with placebo-recombinant Follicle Stimulating Hormone (recFSH); followed by daily SC injections with 200 IU recFSH up to the day of human chorionogonadotropin (hCG); multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; a single dose of hCG (5000 or 10,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of oocyte pick up (OPU) daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mothers recFSH 200 IU</arm_group_label>
    <description>Participants from the Base Trial P05787 who received a single SC injection of placebo Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections with 200 IU recFSH from Stimulation Days 1 to 7; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; a single dose of hCG (5000 or 10,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corifollitropin Alfa 150 μg</intervention_name>
    <description>In the Base Trial P05787, on the morning of day 2 or 3 of the menstrual cycle (Stimulation Day 1), a single SC injection of 150 μg (0.5 mL) Corifollitropin Alfa was administered in the abdominal wall.</description>
    <arm_group_label>Mothers Corifollitropin Alfa 150 µg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>200 IU RecFSH/Follitropin beta (Days 1 to 7)</intervention_name>
    <description>In the Base Trial P05787, daily SC injections with 200 IU fixed dose recFSH were started on Stimulation Day 1 and continued up to and including Stimulation Day 7.</description>
    <arm_group_label>Mothers recFSH 200 IU</arm_group_label>
    <other_name>follitropin beta</other_name>
    <other_name>Puregon®</other_name>
    <other_name>Follistim®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo for Corifollitropin Alfa</intervention_name>
    <description>In the Base Trial P05787, on the morning of day 2 or 3 of the menstrual cycle (Stimulation Day 1), a single SC injection from a pre-filled syringe containing an identical solution when compared to Corifollitropin Alfa was administered in the abdominal wall.</description>
    <arm_group_label>Mothers recFSH 200 IU</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo for RecFSH/Follitropin beta</intervention_name>
    <description>In the Base Trial P05787, daily SC injections of an identical ready-for-use solution, but without the active ingredient, supplied in cartridges for SC injection with the Follistim Pen, were started on Stimulation Day 1 and continued up to and including Stimulation Day 7.</description>
    <arm_group_label>Mothers Corifollitropin Alfa 150 µg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>200 IU RecFSH/Follitropin beta (Days 8 to hCG)</intervention_name>
    <description>In the Base Trial P05787, from Stimulation Day 8 onwards a daily SC dose of 200 IU recFSH was administered up to and including the Day of hCG.</description>
    <arm_group_label>Mothers Corifollitropin Alfa 150 µg</arm_group_label>
    <arm_group_label>Mothers recFSH 200 IU</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ganirelix</intervention_name>
    <description>In the Base Trial P05787, on Stimulation Day 5 a daily SC injection of 0.25 mg was started, which continued up to and including the day of hCG.</description>
    <arm_group_label>Mothers Corifollitropin Alfa 150 µg</arm_group_label>
    <arm_group_label>Mothers recFSH 200 IU</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>hCG</intervention_name>
    <description>In the Base Trial P05787, when 3 follicles &gt;= 17 mm were observed by USS, a single dose of 10,000 IU/USP hCG was administered; or, for those at risk for Ovarian Hyperstimulation Syndrome (OHSS), a lower dose of 5,000 IU/USP</description>
    <arm_group_label>Mothers Corifollitropin Alfa 150 µg</arm_group_label>
    <arm_group_label>Mothers recFSH 200 IU</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Progesterone</intervention_name>
    <description>In the Base Trial P05787, on the day of OPU, luteal phase support was started by administering micronized progesterone of at least 600 mg/day vaginally, or at least 50 mg/day intramuscular (IM), which continued for at least 6 weeks, or up to menses.</description>
    <arm_group_label>Mothers Corifollitropin Alfa 150 µg</arm_group_label>
    <arm_group_label>Mothers recFSH 200 IU</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women with an ongoing pregnancy at least 10 weeks after ET in Base Trial P05787
        (NCT00696800) were enrolled in this trial.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants who received at least one dose of either Corifollitropin Alfa or

        Puregon®/Follistim® AQ Cartridge in Base Trial P05787 (NCT00696800);

          -  Ongoing pregnancy confirmed by ultrasound at least 10 weeks after embryo transfer in
             Base Trial P05787 (NCT00696800);

          -  Able and willing to give written informed consent.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2008</study_first_submitted>
  <study_first_submitted_qc>June 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 20, 2008</study_first_posted>
  <results_first_submitted>November 18, 2014</results_first_submitted>
  <results_first_submitted_qc>November 18, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 24, 2014</results_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neonatal outcome</keyword>
  <keyword>Congenital malformations</keyword>
  <keyword>In-Vitro fertilization</keyword>
  <keyword>Controlled ovarian stimulation</keyword>
  <keyword>Follow-up</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
    <mesh_term>Follicle Stimulating Hormone</mesh_term>
    <mesh_term>Ganirelix</mesh_term>
  </intervention_browse>
  <study_docs>
    <study_doc>
      <doc_type>CSR Synopsis</doc_type>
      <doc_url>http://www.merck.com/clinical-trials/study.html?id=P05712&amp;kw=P05712&amp;tab=access</doc_url>
    </study_doc>
  </study_docs>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Period one consists of mothers from the Base Trial P05787 (NCT00696800), randomized to treatment groups Corifollitropin Alfa (Org 36286) or recombinant Follicle Stimulating Hormone (recFSH). Period two consists of mothers (N = 541) who enrolled in trial P05712. Period three consists of miscarried/stillborn fetuses and infants born in trial P05712.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Mothers Corifollitropin Alfa 150 µg</title>
          <description>Participants from the Base Trial P05787 (NCT00696800) who received a subcutaneous (SC) injection of 150 µg Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections from Stimulation Days 1 to 7 with placebo-recFSH; followed by daily SC injections with 200 IU recFSH up to the day of human Chorion Gonadotropin (hCG); multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; a single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of oocyte pick-up (OPU) daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
        </group>
        <group group_id="P2">
          <title>Mothers recFSH 200 IU</title>
          <description>Participants from the Base Trial P05787 (NCT00696800) who received a single SC injection of placebo Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections with 200 IU recFSH from Stimulation Days 1 to 7; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
        </group>
        <group group_id="P3">
          <title>Fetuses/Infants Corifollitropin Alfa 150 µg</title>
          <description>Fetuses and infants born in Follow Up Trial P05712 to mothers treated with Corifollitropin Alfa 150 µg in Base Trial P05787 (NCT00696800)</description>
        </group>
        <group group_id="P4">
          <title>Fetuses/Infants recFSH 200 IU</title>
          <description>Fetuses and infants born in Follow Up Trial P05712 to mothers treated with recFSH 200 IU in Base Trial P05787 (NCT00696800)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Mothers Base Trial P05787 (NCT00696800)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="757">Randomized in Base Trial P05787 (NCT00696800)</participants>
                <participants group_id="P2" count="752">Randomized in Base Trial P05787 (NCT00696800)</participants>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Treated</title>
              <participants_list>
                <participants group_id="P1" count="756">Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)</participants>
                <participants group_id="P2" count="750">ITT group in Base Trial P05787 (NCT006968000)</participants>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Embryo Transfer</title>
              <participants_list>
                <participants group_id="P1" count="672">Embryo transfer (ET) in Base Trial P05787 (NCT006968000)</participants>
                <participants group_id="P2" count="704">Embryo transfer (ET) in Base Trial P05787 (NCT006968000)</participants>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="295">ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)</participants>
                <participants group_id="P2" count="286">ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)</participants>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="462"/>
                <participants group_id="P2" count="466"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Mothers Follow Up Trial P05712</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="274">Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712</participants>
                <participants group_id="P2" count="267">Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712</participants>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="241">Completed Follow Up in Trial P05712</participants>
                <participants group_id="P2" count="235">Completed Follow Up in Trial P05712</participants>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Did not complete follow up in P05712</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Fetuses/Infants Follow Up Trial P05712</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="352">Fetuses in Follow Up Trial P05712</participants>
                <participants group_id="P4" count="326">Fetuses in Follow Up Trial P05712</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Live Born Infants</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="344">Live born infants in Follow Up Trail P05712</participants>
                <participants group_id="P4" count="315">Live born infants in Follow Up Trail P05712</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="305">Infants in P05712 with Follow Up Completed</participants>
                <participants group_id="P4" count="284">Infants in P05712 with Follow Up Completed</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="47"/>
                <participants group_id="P4" count="42"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Did not complete follow up in P05712</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="47"/>
                <participants group_id="P4" count="42"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Eligible mothers from the Base Trial P05787 (NCT00696800) who enrolled in Follow Up Trial P05712</population>
      <group_list>
        <group group_id="B1">
          <title>Mothers Corifollitropin Alfa 150 µg</title>
          <description>Participants from the Base Trial P05787 (NCT00696800) who received a SC injection of 150 µg Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections from Stimulation Days 1 to 7 with placebo-recFSH; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; a single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
        </group>
        <group group_id="B2">
          <title>Mothers recFSH 200 IU</title>
          <description>Participants from the Base Trial P05787 (NCT00696800) who received a single SC injection of placebo Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections with 200 IU recFSH from Stimulation Days 1 to 7; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="274"/>
            <count group_id="B2" value="267"/>
            <count group_id="B3" value="541"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.4" spread="3.2"/>
                    <measurement group_id="B2" value="31.3" spread="3.5"/>
                    <measurement group_id="B3" value="31.3" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="274"/>
                    <measurement group_id="B2" value="267"/>
                    <measurement group_id="B3" value="541"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Mothers in Current Follow Up Trial Experiencing Adverse Events (AEs)</title>
        <description>An AE is any untoward medical occurrence in a trial participant administered a pharmaceutical product, and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign (including laboratory finding), symptom, or disease temporally associated with the use of investigational medicinal product.</description>
        <time_frame>Up to one day following delivery (up to 1 year)</time_frame>
        <population>Eligible Mothers from the Base Trial P05787 (NCT00696800) who enrolled in the Follow Up Trial P05712. Infants from Follow Up Trial P05712 were not analyzed in this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Mothers Corifollitropin Alfa 150 µg</title>
            <description>Participants from the Base Trial P05787 (NCT00696800) who received a SC injection of 150 µg Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections from Stimulation Days 1 to 7 with placebo-recFSH; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; a single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
          </group>
          <group group_id="O2">
            <title>Mothers recFSH 200 IU</title>
            <description>Participants from the Base Trial P05787 (NCT00696800) who received a single SC injection of placebo Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections with 200 IU recFSH from Stimulation Days 1 to 7; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Mothers in Current Follow Up Trial Experiencing Adverse Events (AEs)</title>
          <description>An AE is any untoward medical occurrence in a trial participant administered a pharmaceutical product, and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign (including laboratory finding), symptom, or disease temporally associated with the use of investigational medicinal product.</description>
          <population>Eligible Mothers from the Base Trial P05787 (NCT00696800) who enrolled in the Follow Up Trial P05712. Infants from Follow Up Trial P05712 were not analyzed in this outcome measure.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="274"/>
                <count group_id="O2" value="267"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="222"/>
                    <measurement group_id="O2" value="214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Mothers in Current Follow Up Trial Experiencing Serious AEs (SAEs)</title>
        <description>A SAE is any untoward medical occurrence that at any dose resulted in the following: death, was life threatening, required in-patient hospitalization or prolongation of existing hospitalization, persistent or significant disability/incapacity, or was a congenital anomaly/birth defect.</description>
        <time_frame>Up to one day following delivery (up to 1 year)</time_frame>
        <population>Eligible Mothers from the Base Trial P05787 (NCT00696800) who enrolled in the Follow Up Trial P05712. Infants from Follow Up Trial P05712 were not analyzed in this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Mothers Corifollitropin Alfa 150 µg</title>
            <description>Participants from the Base Trial P05787 (NCT00696800) who received a SC injection of 150 µg Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections from Stimulation Days 1 to 7 with placebo-recFSH; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; a single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
          </group>
          <group group_id="O2">
            <title>Mothers recFSH 200 IU</title>
            <description>Participants from the Base Trial P05787 (NCT00696800) who received a single SC injection of placebo Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections with 200 IU recFSH from Stimulation Days 1 to 7; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Mothers in Current Follow Up Trial Experiencing Serious AEs (SAEs)</title>
          <description>A SAE is any untoward medical occurrence that at any dose resulted in the following: death, was life threatening, required in-patient hospitalization or prolongation of existing hospitalization, persistent or significant disability/incapacity, or was a congenital anomaly/birth defect.</description>
          <population>Eligible Mothers from the Base Trial P05787 (NCT00696800) who enrolled in the Follow Up Trial P05712. Infants from Follow Up Trial P05712 were not analyzed in this outcome measure.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="274"/>
                <count group_id="O2" value="267"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129"/>
                    <measurement group_id="O2" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Infants Born in Current Follow Up Trial Experiencing AEs</title>
        <description>An AE is any untoward medical occurrence in a trial participant administered a pharmaceutical product, and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign (including laboratory finding), symptom, or disease temporally associated with the use of investigational medicinal product.</description>
        <time_frame>Up to 12 weeks following delivery (up to 1 year)</time_frame>
        <population>Infants born in Follow Up Trial P05712. Mothers were not analyzed in this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Infants Corifollitropin Alfa 150 µg</title>
            <description>Infants born in Follow Up Trial P05712 to mothers treated with Corifollitropin Alfa 150 µg in Base Trial P05787 (NCT00696800)</description>
          </group>
          <group group_id="O2">
            <title>Infants recFSH 200 IU</title>
            <description>Infants born in Follow Up Trial P05712 to mothers treated with recFSH 200 IU in Base Trial P05787 (NCT00696800)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Infants Born in Current Follow Up Trial Experiencing AEs</title>
          <description>An AE is any untoward medical occurrence in a trial participant administered a pharmaceutical product, and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign (including laboratory finding), symptom, or disease temporally associated with the use of investigational medicinal product.</description>
          <population>Infants born in Follow Up Trial P05712. Mothers were not analyzed in this outcome measure.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="344"/>
                <count group_id="O2" value="315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="164"/>
                    <measurement group_id="O2" value="161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Infants in Current Follow Up Trial Experiencing SAEs</title>
        <description>A SAE is any untoward medical occurrence that at any dose resulted in the following: death, was life threatening, required in-patient hospitalization or prolongation of existing hospitalization, persistent or significant disability/incapacity, or was a congenital anomaly/birth defect.</description>
        <time_frame>Up to 12 weeks following delivery (up to 1 year)</time_frame>
        <population>Infants born in Follow Up Trial P05712. Mothers were not analyzed in this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Infants Corifollitropin Alfa 150 µg</title>
            <description>Infants born in Follow Up Trial P05712 to mothers treated with Corifollitropin Alfa 150 µg in Base Trial P05787 (NCT00696800)</description>
          </group>
          <group group_id="O2">
            <title>Infants recFSH 200 IU</title>
            <description>Infants born in Follow Up Trial P05712 to mothers treated with recFSH 200 IU in Base Trial P05787 (NCT00696800)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Infants in Current Follow Up Trial Experiencing SAEs</title>
          <description>A SAE is any untoward medical occurrence that at any dose resulted in the following: death, was life threatening, required in-patient hospitalization or prolongation of existing hospitalization, persistent or significant disability/incapacity, or was a congenital anomaly/birth defect.</description>
          <population>Infants born in Follow Up Trial P05712. Mothers were not analyzed in this outcome measure.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="344"/>
                <count group_id="O2" value="315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106"/>
                    <measurement group_id="O2" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Mothers From the Base Trial P05787 With at Least One Live Born Infant (Take-home Baby Rate) Relative to the Number of Participants in the Base Trial.</title>
        <description>The take-home baby rate is 100 X the number of participants with an ongoing pregnancy in Base Trial P05787 (NCT00696800), from the Intent-to-Treat (ITT) group, with at least one live born infant relative to the number of participants in the Base Trial.</description>
        <time_frame>At least 10 weeks after embryo transfer in Base Trial P05787 up to birth in current follow up Trial (up to 1 year)</time_frame>
        <population>Mothers from the ITT group of the Base Trial P05787 (NCT00696800). Infants from Follow Up Trial P05712 were not analyzed in this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Mothers Corifollitropin Alfa 150 µg</title>
            <description>Participants from the Base Trial P05787 (NCT00696800) who received a SC injection of 150 µg Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections from Stimulation Days 1 to 7 with placebo-recFSH; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; a single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
          </group>
          <group group_id="O2">
            <title>Mothers recFSH 200 IU</title>
            <description>Participants from the Base Trial P05787 (NCT00696800) who received a single SC injection of placebo Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections with 200 IU recFSH from Stimulation Days 1 to 7; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Mothers From the Base Trial P05787 With at Least One Live Born Infant (Take-home Baby Rate) Relative to the Number of Participants in the Base Trial.</title>
          <description>The take-home baby rate is 100 X the number of participants with an ongoing pregnancy in Base Trial P05787 (NCT00696800), from the Intent-to-Treat (ITT) group, with at least one live born infant relative to the number of participants in the Base Trial.</description>
          <population>Mothers from the ITT group of the Base Trial P05787 (NCT00696800). Infants from Follow Up Trial P05712 were not analyzed in this outcome measure.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="756"/>
                <count group_id="O2" value="750"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.6"/>
                    <measurement group_id="O2" value="34.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Mothers From the Base Trial P05787 With at Least One Live Born Infant (Take-home Baby Rate) Relative to the Number of Participants From the Base Trial With Embryo Transfer.</title>
        <description>The take-home baby rate is 100 X the number of participants with an ongoing pregnancy in Base Trial P05787 (NCT00696800), from the ITT group, with at least one live born infant relative to the number of participants from the Base Trial with embryo transfer.</description>
        <time_frame>At least 10 weeks after embryo transfer in Base Trial P05787 up to birth in current Follow Up Trial (up to 1 year)</time_frame>
        <population>Mothers from the ITT group of the Base Trial P05787 (NCT00696800) who had ET. Infants from Follow Up Trial P05712 were not analyzed in this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Mothers Corifollitropin Alfa 150 µg</title>
            <description>Participants from the Base Trial P05787 (NCT00696800) who received a SC injection of 150 µg Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections from Stimulation Days 1 to 7 with placebo-recFSH; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; a single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
          </group>
          <group group_id="O2">
            <title>Mothers recFSH 200 IU</title>
            <description>Participants from the Base Trial P05787 (NCT00696800) who received a single SC injection of placebo Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections with 200 IU recFSH from Stimulation Days 1 to 7; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Mothers From the Base Trial P05787 With at Least One Live Born Infant (Take-home Baby Rate) Relative to the Number of Participants From the Base Trial With Embryo Transfer.</title>
          <description>The take-home baby rate is 100 X the number of participants with an ongoing pregnancy in Base Trial P05787 (NCT00696800), from the ITT group, with at least one live born infant relative to the number of participants from the Base Trial with embryo transfer.</description>
          <population>Mothers from the ITT group of the Base Trial P05787 (NCT00696800) who had ET. Infants from Follow Up Trial P05712 were not analyzed in this outcome measure.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="672"/>
                <count group_id="O2" value="704"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.0"/>
                    <measurement group_id="O2" value="36.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Mothers: up to one day after delivery; Fetuses and Infants: up to 12 weeks after birth</time_frame>
      <desc>All study treatments were considered to be administered to the mother.</desc>
      <group_list>
        <group group_id="E1">
          <title>Mothers Corifollitropin Alfa 150 µg</title>
          <description>Participants from the Base Trial P05787 (NCT00696800) who received a SC injection of 150 µg Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections from Stimulation Days 1 to 7 with placebo-recFSH; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; a single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
        </group>
        <group group_id="E2">
          <title>Mothers recFSH 200 IU</title>
          <description>Participants from the Base Trial P05787 (NCT00696800) who received a single SC injection of placebo Corifollitropin Alfa on day 2 or 3 of the menstrual cycle (Stimulation Day 1); 7 daily SC injections with 200 IU recFSH from Stimulation Days 1 to 7; followed by daily SC injections with 200 IU recFSH up to the day of hCG; multiple daily SC injections of Ganirelix from Stimulation Day 5 to the day of hCG; single dose of hCG (10,000 or 5,000 IU/USP) was administered when 3 follicles &gt;= 17 mm were observed; and on the day of OPU daily doses of progesterone were started and continued for up to 6 weeks or menses. Eligible participants from the Base Trial were enrolled in Follow Up Trial P05712, where no study treatments were given, and pregnancy, delivery and neonatal outcome were monitored.</description>
        </group>
        <group group_id="E3">
          <title>Fetuses/Infants Corifollitropin Alfa 150 µg</title>
          <description>Fetuses and infants born in Follow Up Trial P05712 to mothers treated with Corifollitropin Alfa 150 µg in Base Trial P05787 (NCT00696800)</description>
        </group>
        <group group_id="E4">
          <title>Fetuses/Infants recFSH 200 IU</title>
          <description>Fetuses and infants born in Follow Up Trial P05712 to mothers treated with recFSH 200 IU in Base Trial P05787 (NCT00696800)</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 12.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="129" subjects_at_risk="274"/>
                <counts group_id="E2" subjects_affected="117" subjects_at_risk="267"/>
                <counts group_id="E3" subjects_affected="106" subjects_at_risk="352"/>
                <counts group_id="E4" subjects_affected="94" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Placental transfusion syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Splenomegaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Bradycardia foetal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Bradycardia neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cardiac hypertrophy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Nodal rhythm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Pulmonary valve stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Tachycardia foetal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal palmar/planta creases</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Accessory auricle</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Ankyloglossia congenital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Atrial septal defect</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="352"/>
                <counts group_id="E4" events="11" subjects_affected="11" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Atrioventricular septal defect</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Bat ear</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cervical rib</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Chondrodystrophy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cleft lip</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cleft palate</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cleft uvula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Clinodactyly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital aortic anomaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital aortic stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital aortic valve stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital central nervous system anomaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital cerebral cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital choroid plexus cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital coronary artery malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital eyelid malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital foot malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital hand malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital hearing disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital hip deformity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital hydrocephalus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital inguinal hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital labia pudendi adhesions</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital mitral valve stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital naevus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital nose malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital optic nerve anomaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital ovarian anomaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital pyelocaliectasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital spinal cord anomaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital torticollis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Congenital tracheomalacia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Craniotabes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cryptorchism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Dacryostenosis congenital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="352"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Duodenal atresia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Exomphalos</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Eyelid ptosis congenital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Fallot's tetralogy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Gastrointestinal malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Haemangioma congenital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Heart disease congenital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hip dysplasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hypertelorism of orbit</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hypospadias</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Immunodeficiency congenital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Patent ductus arteriosus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="352"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Phimosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Pilonidal cyst congenital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Plagiocephaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Pulmonary artery stenosis congenital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Pulmonary valve stenosis congenital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Pyloric stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Rhesus haemolytic disease of newborn</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Single umbilical artery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Skull malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Strabismus congenital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Supernumerary nipple</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Syndactyly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Talipes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Tracheo-oesophageal fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Trisomy 21</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Ventricular septal defect</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Hearing impaired</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Secondary hypogonadism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Dacryostenosis acquired</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Eye disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Lacrimal cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Retinopathy of prematurity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Anal stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Necrotising enterocolitis neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Short-bowel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Drug withdrawal syndrome neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Fever neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Neonatal multi-organ faillure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Sudden infant death syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperbilirubinaemia neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="352"/>
                <counts group_id="E4" events="8" subjects_affected="8" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Neonatal cholestasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Genital herpes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Klebsiella sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Meningitis streptococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Neonatal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Neonatal pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Oral candidiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Respiratory syncytial virus bronchiolitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Respiratory syncytial virus infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Sepsis neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="352"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Acoustic stimulation tests abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Amniotic fluid volume decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Blood glucose decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Blood glucose fluctuation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Blood sodium increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Body temperature decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>C-reactive protein increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cardiac murmur</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cytomegalovirus antibody positive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Foetal heart rate abnormal</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Foetal heart rate decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Haemoglobin Barts present</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Cow's milk intolerance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Fatty acid deficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Gestational diabetes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hypermagnesaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Loctose intolerance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Neonatal hyponatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Head deformity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hypotonia neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Joint range of motion decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Osteopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Positional plagiocephaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Posture abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Haemangioma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Haemangioma of skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Lymphangioma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cerebral ventricle dilatation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Convulsion neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Encephalopathy neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Intraventricular haemorrhage neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Neurological symptom</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Superior sagittal sinus thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion spontaneous</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Antepartum haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Arrested labour</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="274"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Breech presentation</sub_title>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="274"/>
                <counts group_id="E2" events="23" subjects_affected="23" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Caput succedaneum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cephalo-pelvic disproportion</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="274"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Cervical incompetence</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Chorioamnionitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Discordant twin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Face presentation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Failed induction of labour</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Foetal distress syndrome</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="274"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Foetal growth retardation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Foetal hypokinesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Foetal macrosomia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Foetal malposition</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Foetal malpresentation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="274"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>HELLP syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hydrops foetalis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hyperemesis gravidarum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Imminent abortion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Intrapartum haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Jaundice neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="352"/>
                <counts group_id="E4" events="8" subjects_affected="8" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Meconium in amniotic fluid</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Meconium stain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Multiple pregnancy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Oligohydramnios</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Placenta accreta</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Placenta praevia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Polyhydramnios</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Postpartum haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Pre-eclampsia</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="274"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Pregnancy induced hypertension</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="274"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Premature baby</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="56" subjects_affected="56" subjects_at_risk="352"/>
                <counts group_id="E4" events="48" subjects_affected="48" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Premature labour</sub_title>
                <counts group_id="E1" events="37" subjects_affected="37" subjects_at_risk="274"/>
                <counts group_id="E2" events="33" subjects_affected="33" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Premature rupture of membranes</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="274"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Premature separation of placenta</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Previous caesarean section</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Prolonged labour</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Small for dates baby</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="352"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Stillbirth</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Threatened labour</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="274"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Transverse presentation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="274"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Twin pregnancy</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="274"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Umbilical cord abnormality</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Umbilical cord around neck</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Umbilical cord prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Uterine contractions during pregnancy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Uterine hypotonus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Post-traumatic stress disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Renal failure neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Renal tubular necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Cervix oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Chordee</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Haemorrhagic ovarian cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Ovarian enlargement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Ovarian hyperstimulation syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Ovarian torsion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Shortened cervix</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Uterine atony</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Apnoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Apparent life threatening event</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Atelectasis neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Bronchopulmonary dysplasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Infantile apnoeic attack</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Neonatal hypoxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Neonatal respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="13" subjects_affected="13" subjects_at_risk="352"/>
                <counts group_id="E4" events="12" subjects_affected="12" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Neonatal respiratory failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Neonatal tachypnoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Pneumomediastinum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Respiratory disorder neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Transient tachypnoea of the newborn</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Hair growth abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Abortion induced</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Appendicectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Caesarean section</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Evacuation of retained products of conception</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Labour induction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Selective abortion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hypertension neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Hypoperfusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Lymphocele</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Neonatal hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="352"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 12.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="112" subjects_at_risk="274"/>
                <counts group_id="E2" subjects_affected="118" subjects_at_risk="267"/>
                <counts group_id="E3" subjects_affected="37" subjects_at_risk="352"/>
                <counts group_id="E4" subjects_affected="41" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="274"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="274"/>
                <counts group_id="E2" events="23" subjects_affected="22" subjects_at_risk="267"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="352"/>
                <counts group_id="E4" events="8" subjects_affected="8" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="31" subjects_affected="27" subjects_at_risk="274"/>
                <counts group_id="E2" events="23" subjects_affected="22" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="274"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="267"/>
                <counts group_id="E3" events="16" subjects_affected="16" subjects_at_risk="352"/>
                <counts group_id="E4" events="17" subjects_affected="17" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="22" subjects_affected="20" subjects_at_risk="274"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="38" subjects_affected="34" subjects_at_risk="274"/>
                <counts group_id="E2" events="29" subjects_affected="27" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="19" subjects_affected="17" subjects_at_risk="274"/>
                <counts group_id="E2" events="17" subjects_affected="15" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Oedema Peripheral</sub_title>
                <counts group_id="E1" events="26" subjects_affected="21" subjects_at_risk="274"/>
                <counts group_id="E2" events="16" subjects_affected="13" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Gestational diabetes</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="274"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="28" subjects_affected="25" subjects_at_risk="274"/>
                <counts group_id="E2" events="25" subjects_affected="20" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="31" subjects_affected="24" subjects_at_risk="274"/>
                <counts group_id="E2" events="37" subjects_affected="31" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Antepartum haemorrhage</sub_title>
                <counts group_id="E1" events="21" subjects_affected="19" subjects_at_risk="274"/>
                <counts group_id="E2" events="19" subjects_affected="14" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Jaundice neonatal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="274"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E3" events="22" subjects_affected="22" subjects_at_risk="352"/>
                <counts group_id="E4" events="20" subjects_affected="20" subjects_at_risk="326"/>
              </event>
              <event>
                <sub_title>Threatened labour</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="274"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" events="18" subjects_affected="14" subjects_at_risk="274"/>
                <counts group_id="E2" events="16" subjects_affected="10" subjects_at_risk="267"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="352"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="326"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Any scientific paper, presentation, or other communication concerning the clinical trial will first be presented to the Sponsor, at least six weeks ahead of estimated publication or presentation, for written consent. The Sponsor shall have the right to make its consent conditional upon proper representation of the interpretation of both the Sponsor and the investigator(s) in the discussion of the data in such communications.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Vice President, Global Clinical Development</name_or_title>
      <organization>Merck Sharp &amp; Dohme Corp</organization>
      <phone>1-800-672-6372</phone>
      <email>ClinicalTrialsDisclosure@merck.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

